Effects of Fibromyalgia Syndrome in Patients With Systemic Sclerosis

CompletedOBSERVATIONAL
Enrollment

140

Participants

Timeline

Start Date

January 2, 2019

Primary Completion Date

December 20, 2019

Study Completion Date

December 20, 2019

Conditions
Systemic SclerosisFibromyalgia
Interventions
DIAGNOSTIC_TEST

Fibromyalgia diagnosis in patients with SSc

American College of Rheumatology (ACR) FMS diagnostic criteria set:It is evaluated by the common pain index \[WPI\] and symptom severity (SS) scale \[19\]. Diffuse pain index \[WPI\]; It is a scale that can be scored between 0-19 and obtained by indicating the aching regions of the patient during the last 1 week. Right shoulder, left shoulder, right hip \[gluteal region\], left hip \[gluteal region\], left chin, right chin, left upper arm, left lower arm, right upper arm, right lower arm, left upper leg, left lower leg, includes right upper leg, right lower leg, chest, neck, abdomen, upper back, lower back. Symptom Severity Scale \[SSS\]; evaluates weakness, tired awakening and cognitive functions. In addition, muscle pain, weakness, irritable bowel syndrome, memory problems, headache, abdominal pain, numbness, dizziness, insomnia, depression, constipation, irritability, dry mouth etc. It also evaluates somatic symptoms.

Trial Locations (1)

Unknown

Ethics Commitee of Antalya Training and Research Hospital, Antalya

All Listed Sponsors
lead

Antalya Training and Research Hospital

OTHER_GOV

NCT04411498 - Effects of Fibromyalgia Syndrome in Patients With Systemic Sclerosis | Biotech Hunter | Biotech Hunter